SurgiAI
PrivateLast Round
Accelerator
Jan 1, 2025
Total Funding Raised
$800,000
Company Overview
SurgiAI operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was an Accelerator round in January 2025.
SurgiAI is a health tech company that develops an AI-powered surgical guidance platform designed to provide real-time anatomical insights and tissue tracking for improved surgical precision.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Computer Vision, Medical Imaging
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SurgiAI Comparables
Compare SurgiAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Semaphor Surgical | 77% | |
| Zeta Surgical | 77% | |
| Surgical Theater | 73% |
For institutional investors. Book with your work email.
SurgiAI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 1, 2025 | ||||
| Seed | Nov 12, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SurgiAI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| eHealth Ventures | Seed |
| IBM Alpha Zone Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
Received funding from Hadassa Medical and IBM Alpha Zone Accelerator.
- Nov 12, 2024
$800K round from eHealth Ventures and Israel Innovation Authority.
For institutional investors. Book with your work email.
SurgiAI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SurgiAI's valuation, stock price, and market status.
Is SurgiAI a public or private company?
SurgiAI is a private company.
What is the current stock price of SurgiAI?
SurgiAI is a private company, so its shares have no public market price. Caplight tracks SurgiAI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SurgiAI worth (valuation)?
Valuation information for SurgiAI is not publicly available.
Can I buy SurgiAI stock?
SurgiAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SurgiAI's last funding round?
SurgiAI's most recent funding round was Accelerator on January 1, 2025.
Who are the main investors in SurgiAI?
Key investors in SurgiAI include Israel Innovation Authority, eHealth Ventures, IBM Alpha Zone Accelerator.
Will SurgiAI IPO soon?
No public IPO plans have been announced for SurgiAI.
How can I track SurgiAI secondary market activity?
Caplight tracks bids, offers, and trades in SurgiAI's shares on secondary markets.